Corena Acquired by EarlyHealth to Boost Life-Sciences Growth in Turkey
Deal News | Jun 18, 2025 | Globenewswire
EarlyHealth Group, a global pharmaceutical service provider, has announced the acquisition of Corena Ecza Deposu, Turkey's leading pharmaceutical distributor. This acquisition aims to strengthen EarlyHealth's position in the Turkish life sciences sector. The initiative is part of a broader strategy to push forward a $100 million portfolio aimed at globalizing the Turkish pharmaceutical market. The acquisition will enhance support for government export initiatives, strengthen academia-industry collaboration, and accelerate Turkey's role in clinical research and pharmaceutical innovation. Dr. Dan A. Renout, CEO of EarlyHealth, and Mrs. Nihal Aygın, owner of Corena, emphasized their long-standing partnership and commitment to reducing Turkey's dependency on pharmaceutical imports. The acquisition was formally signed in Dubai, attended by significant figures like Turkish General Consul Onur Saylan and members of the Abu Dhabi royal family, with a focus on innovation in healthcare and cross-border investments.
Sectors
- Life Sciences
- Pharmaceuticals
Geography
- Turkey – The acquisition of Corena Ecza Deposu, a major pharmaceutical distributor in Turkey, signifies a strategic expansion in the Turkish market.
- United Arab Emirates – The formal acquisition event was held in Dubai, highlighting the UAE's role in facilitating cross-border investments.
Industry
- Life Sciences – The acquisition enhances EarlyHealth's footprint in the life sciences sector by integrating Corena’s distribution strength with EarlyHealth’s global platform.
- Pharmaceuticals – Corena as a leading pharmaceutical distributor in Turkey, is crucial for EarlyHealth's strategic expansion in the pharmaceutical market.
Financials
- 100 million USD – The growth target for the Turkish life-sciences sector initiated by EarlyHealth Group through the acquisition of Corena.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| EarlyHealth Group | Acquirer | Company | A global pharmaceutical service provider supporting clinical research and market access in the life sciences industry. |
| Corena Ecza Deposu | Target Company | Company | Turkey's leading pharmaceutical distributor, focusing on reducing import dependency and strengthening the pharmaceutical supply chain. |
| Onur Saylan | Turkish General Consul in UAE | Government | Represented the Turkish government at the acquisition event, emphasizing the partnership between Turkey and the UAE. |
| Nihal Aygın | Owner of Corena | Person | Owning party selling Corena, committed to national pharmaceutical initiatives. |
| Dan A. Renout | CEO of EarlyHealth Group | Person | Leading EarlyHealth's strategic expansion into the Turkish pharmaceutical market. |